Modulators of Nuclear Receptor Co-regulatory Protein Binding
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling, methods for inhibiting the interaction between a co-regulatory protein and an androgen or estrogen receptor, and methods for treating cancer.
Patents:US 20,110,105,608
Inventor(s):
HANSON ROBERT N [US]
Type of Offer:
Licensing
« More Biotech Patents